...
首页> 外文期刊>Vaccine >Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge
【24h】

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

机译:DNA免疫接种牛痘病毒包膜蛋白在保护BALB / c小鼠免受致命鼻内痘病毒攻击方面的差异性功效

获取原文
获取原文并翻译 | 示例

摘要

DNA vaccines might offer an alternative to the live smallpox vaccine in providing protective efficacy in an orthopoxvirus (OPV) lethal respiratory challenge model. BALB/c mice were immunised with DNA vaccines coding for 10 different single vaccinia virus (VACV) membrane proteins. After an intranasal challenge with the VACV IHD strain, three gene candidates B5R, A33R and A27L produced > or =66% survival. The B5R DNA vaccine consistently produced 100% protection and exhibited greatest efficacy after three 50 microg intramuscular doses in this model. Sero-conversion to these vaccines was often inconsistent, implying that antibody itself was not a correlate of protection. The B5R DNA vaccine induced a strong and consistent gamma interferon (IFNgamma) response in BALB/c mice given a single DNA vaccine dose. Strong IFNgamma responses were also measured in pTB5R immunised C57BL6 mice deficient for MHC class I molecules, suggesting that the memory response was mediated by a CD4+ T cell population.
机译:DNA疫苗可能会替代活天花疫苗,从而在正痘病毒(OPV)致死性呼吸道攻击模型中发挥保护作用。用编码10种不同的单痘苗病毒(VACV)膜蛋白的DNA疫苗免疫BALB / c小鼠。在用VACV IHD菌株进行鼻内攻击后,三种基因候选物B5R,A33R和A27L的存活率≥66%。在此模型中,三剂50微克的肌肉注射后,B5R DNA疫苗始终产生100%的保护,并显示出最大的功效。对这些疫苗的血清转化通常是不一致的,这表明抗体本身与保护作用无关。给予单剂量DNA疫苗后,B5R DNA疫苗在BALB / c小鼠中诱导了强而一致的伽马干扰素(IFNgamma)反应。在缺乏MHC I类分子的pTB5R免疫C57BL6小鼠中也检测到强IFNγ反应,这表明记忆反应是由CD4 + T细胞群体介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号